EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

First-line fluoropyrimidine- versus gemcitabine-based chemotherapy for metastatic recurrence after resection of ampullary adenocarcinoma: A real-world analysis of the FFCD-AC cohort

Erwan Vo-Quang, Vincent Hautefeuille, Olivier Bouché, Karine Le Malicot, David Tougeron, Stéphanie Truant, Anna Pellat, Morgane Amil, Gael Roth, Marine Jary, Sylvain Manfredi, Marielle Guillet und 3 weitere

European Journal of Cancer · 2026-11 · 248 · 117775

DOI: 10.1016/j.ejca.2026.117775 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Erwan Vo-Quang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Digestive Oncology Department, Georges Pompidou European Hospital, AP-HP, Paris, France; Centre de Recherche des Cordeliers, Sor…. Hauptthemen laut MEDLINE: Adenocarcinoma, Ampulla of Vater, Antineoplastic Combined Chemotherapy Protocols, Common Bile Duct Neoplasms. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaAmpulla of VaterAntineoplastic Combined Chemotherapy ProtocolsCommon Bile Duct NeoplasmsDeoxycytidineFluorouracilNeoplasm Recurrence, LocalAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedFranceGemcitabineProgression-Free SurvivalProspective Studies

Stichwörter der Autor:innen

Ampullary carcinomaChemotherapyFluoropyrimidineGemcitabineMetastatic cancerPrognosisReal-world dataSurvival

Substanzen

DeoxycytidineFluorouracilGemcitabine

Autor:innen und Institutionen

  • Gastroenterology and Digestive Oncology Department, Georges Pompidou European Hospital, AP-HP, Paris, France; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Personalized Medicine…
  • Hepato-gastroenterology and Digestive Oncology, Amiens University Hospital, Amiens, France.
  • Digestive Oncology Department, CHU Reims, Reims, France.
  • Fédération Francophone de Cancérologie digestive (FFCD), Dijon, France; Université Bourgogne Europe, INSERM CTM 1231 EPICAD, Dijon, France.
  • Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
  • Department of Digestive Surgery and Transplantation, CHU Lille, Lille, F-59000, France; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies…

Zitieren

APA

Vo-Quang, E., Hautefeuille, V., Bouché, O., Le Malicot, K., Tougeron, D., Truant, S., Pellat, A., Amil, M., Roth, G., Jary, M., Manfredi, S., Guillet, M., Glehen, O., Taieb, J., & Gallois, C. (2026). First-line fluoropyrimidine- versus gemcitabine-based chemotherapy for metastatic recurrence after resection of ampullary adenocarcinoma: A real-world analysis of the FFCD-AC cohort. European Journal of Cancer, 248, 117775. https://doi.org/10.1016/j.ejca.2026.117775

Vancouver

Vo-Quang E, Hautefeuille V, Bouché O, Le Malicot K, Tougeron D, Truant S, et al. First-line fluoropyrimidine- versus gemcitabine-based chemotherapy for metastatic recurrence after resection of ampullary adenocarcinoma: A real-world analysis of the FFCD-AC cohort. European Journal of Cancer. 2026;248:117775. doi:10.1016/j.ejca.2026.117775

BibTeX
@article{VoQuang2026,
  author = {Vo-Quang, Erwan and Hautefeuille, Vincent and Bouché, Olivier and Le Malicot, Karine and Tougeron, David and Truant, Stéphanie and Pellat, Anna and Amil, Morgane and Roth, Gael and Jary, Marine and Manfredi, Sylvain and Guillet, Marielle and Glehen, Olivier and Taieb, Julien and Gallois, Claire},
  title = {First-line fluoropyrimidine- versus gemcitabine-based chemotherapy for metastatic recurrence after resection of ampullary adenocarcinoma: A real-world analysis of the FFCD-AC cohort},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117775},
  doi = {10.1016/j.ejca.2026.117775}
}
Kostenlos starten →